Matthew Herper on Muck Rack

Matthew Herper Verified

New York
Senior Editor — Forbes
As seen in:  Forbes

Forbes reporter covering science and medicine

Juno Shares Exploded Post-IPO. Should You Consider Buying Them?

forbes.com — One of the most exciting companies in biotech just had one of the year's most exciting initial public offerings. Shares of Seattle-based Juno Therapeutics increased 60% from their listing price to $38 in late morning trading in the biggest biotech IPO of the year. The company will have a total market [...]

Biotech Entrepreneur Tony Coles Takes Aim At Parkinson's and Alzheimer's

forbes.com — Tony Coles, the chief executive who sold Onyx Pharmaceuticals to Amgen for $10.4 billion in 2013, is starting a new company that will use yeast to try and discover new treatments for Parkinson's, Alzheimer's, and amyotrophic lateral sclerosis (ALS, also known as Lou Gehring's disease.) The new startup, Yumanity, will be [...]

Watch A Man Tell How Killer T-Cells Eradicated His Cancer

forbes.com — There's probably not a hotter area of biotechnology right now than what's known as CART therapy, in which a patient's own white blood cells are genetically engineered to attack cancer. Earlier this month Novartis announced that 36 of 39 children with acute lymphocytic leukemia that had failed standard treatments saw [...]

How DNA Sequencing In Sewers Could Detect Disease Outbreaks

forbes.com — Disease prevention and mapmaking have been inextricably intertwined since 1854, when an English physician named John Snow plotted a cholera outbreak on a grid to locate-and shut down-a bacteria-tainted water pump, inventing the modern science of epidemiology along the way.

Many Senior Citizens Take Too Many Medicines -- Here's How To Fix It

forbes.com — One recent analysis by the IMS Institute for Healthcare Informatics found that people aged 65-79 receive more than 27 prescriptions for new drugs per year. Let me say that again: Twenty-seven prescriptions per year. Not only is this a high number, it's also a concern. Consider the possible drug interactions and side effects.

Here Is What 60 Minutes Didn't Tell You About The Billionaire Who Is Trying To Disrupt Cancer Care

forbes.com — CBS' fabled newsmagazine show "60 Minutes" just spent 12 minutes showing viewers everything there is to love about Patrick Soon-Shiong, the doctor who is the richest man in L.A. and, actually, the richest physician in the world. As I wrote in a Forbes cover story in September, Soon-Shiong is rolling out [...]

Viewing A Genome On A Blackberry Phone

forbes.com — Patrick Soon-Shiong, the richest doctor in the world, and Blackberry Chief Executive John Chen made some news at Thursday's Forbes Healthcare Summit, revealing a new app that will allow doctors to review a cancer patient's genes on a Blackberry phone. Soon-Shiong also announced that we should expect an initial public offering [...]

Ebola, Ethics, And The New Normal Of Scary Germs

forbes.com — Are you thinking of the Ebola outbreak as a flash-in-the-pan, a problem we've outdistanced? Think again: Ebola virus and other emerging infectious diseases for which we don't have effective treatments are the reality in public health. And they're expected to keep on coming. "This is the new normal," says Luciana Borio, [...]

FDA: Some Ebola Patients Need To Get Placebo

forbes.com — There's been a pretty fierce debate in public health circles over a pressing question: when testing drugs to treat Ebola virus or vaccines that might prevent infection, do we need to do randomized controlled trials in which some patients get placebo, or is Ebola -- like some forms of cancer [...]

New 'Hutch' Director Aims To Push Toward Cancer Cures Based On The Immune System

forbes.com — This morning, the Fred Hutchinson Cancer Research Center in Seattle, a hotbed for the development of new treatments that harness the immune system against cancer, is announcing that it has hired former Merck cancer research boss Gary Gilliland as its next director. "I'm really excited about this," said Gilliland, 60, in [...]
More Articles →
Dec 20, 2014

@westr @illumina Your phenotype is already evident. What light does your genotype shed on it?

Dec 20, 2014

@westr @illumina Maybe. Or, with current technology, you might not learn anything.

Dec 20, 2014

@westr @illumina it must. so does life in general, though. plenty of not-so-healthy people in college though.

Dec 20, 2014

@westr @illumina I will be writing about this, and would love to hear people's thoughts.

Dec 20, 2014

RT @stevesilberman: If you missed it: BMJ study finds that Dr. Oz, "America's doctor," is a quack at least half the time. washingtonpost.com/news/morning-m…

Dec 20, 2014

RT @ReformedBroker: Bombshell - Reuters saying AdvisorHub tried to sell out its readers to the firms they work for. Site is now down. reuters.com/article/2014/1…

Dec 19, 2014

Not starting a price war = favor MT @ArmstrongDrew don't know if $ABBV did the drug industry any favors, in terms of complaints about price.

Learn how to connect with Matthew on social media by joining Muck Rack Pro



Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.


Share This Profile